| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | Australia | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 1 | |
| #5 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Unspecified technologies | |
| #5 | Enzymes | |
| #6 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Van Dyke Thomas E | 8 |
| #2 | Kantarci Alpdogan | 7 |
| #3 | Hasturk Hatice | 7 |
| #4 | Kansal Shevali | 3 |
| #5 | Sands Roger Warren | 2 |
| #6 | Barros E Silva Eduardo Alexandre | 2 |
| #7 | Kawai Toshihisa | 2 |
| #8 | Mooney David J | 2 |
| #9 | Toshihisa Kawai | 1 |
| #10 | Hamilton James A | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP3463419A1 | Compositions and methods of treating cancer using lipid agonists and receptors thereof | |
| US2016354462A1 | Vaccine and therapeutic delivery system | |
| EP2958560A1 | Methods for increasing oral ostenogenesis using lipoxin a4 (lxa4) and its analogs | |
| AU2010278702A1 | Programming of cells for tolerogenic therapies | |
| ZA200800401B | Tuberculosis antigen detection assays and vaccines |